Rabeprazole Sodium (Enteric Coated) and Domperidone (SR) Capsules
Rabivion DSR
Rabeprazole Sodium 20 mg
Domperidone 30 mg (SR)
Clinical Indications for Rabivion DSR:
- Suppresses gastric acid secretion by inhibiting the gastric H+/K+ATPase
- Bioavailability is about 52% & not altered by co-intake of food or antacids
- Produces fast onset of action compared to other ppi's
- Reduces the frequency and severity of heartburn to greater extent than ranitidine
- Relieves both day and night time heart burn
- Increases lower esophageal tone & esophageal clearance
- Eliminates the nausea & vomiting associated with GERD
- Used for its prokinetic actions in dyspepsia



